ClearFlow is revolutionizing the recovery process for patients following therapeutic intervention. The Company’s proprietary Active Clearance Technology® (ACT®) advances healing by preventing post-operative complications associated with retained blood and fluid. ClearFlow’s first commercial solution, the PleuraFlow® ACT® System, improves outcomes for cardiac surgery patients by preventing the most harmful post-operative complications associated with retained blood. The System seamlessly integrates into clinical workflow. Numerous published studies document dramatic improvement in both quality and cost of care. The Company’s customers include leading healthcare providers such as Cleveland Clinic, Mayo Clinic and Columbia Presbyterian. ClearFlow’s product pipeline comprises solutions designed to improve cost and quality of care across multiple markets totaling $1.3 billion, addressing the unmet need of clearance of retained fluids following therapeutic intervention.